申请人:Gruenenthal GmbH
公开号:US20190185470A1
公开(公告)日:2019-06-20
The invention relates to compounds according to general formula (I),
which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.
该发明涉及符合通用公式(I)的化合物,这些化合物作为糖皮质激素受体的调节剂,并可用于治疗和/或预防至少部分通过糖皮质激素受体介导的疾病。